APA (7th ed.) Citation

Kongruang, A., Limsuwanachot, N., Magmuang, S., Areesirisuk, P., Niparuck, P., Siriboonpiputtana, T., & Rerkamnuaychoke, B. (2023). Committed change of real-time quantitative PCR to droplet digital PCR for monitoring BCR: :ABL1 transcripts in tyrosine kinase inhibitor treated CML. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Kongruang, Adcharee, Nittaya Limsuwanachot, Sutada Magmuang, Prapatsorn Areesirisuk, Pimjai Niparuck, Teerapong Siriboonpiputtana, and Budsaba Rerkamnuaychoke. Committed Change of Real-time Quantitative PCR to Droplet Digital PCR for Monitoring BCR: :ABL1 Transcripts in Tyrosine Kinase Inhibitor Treated CML. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Kongruang, Adcharee, et al. Committed Change of Real-time Quantitative PCR to Droplet Digital PCR for Monitoring BCR: :ABL1 Transcripts in Tyrosine Kinase Inhibitor Treated CML. Taylor & Francis Group, 2023.